ScoreWhy is Bliss GVS Pharma Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
Poor long term growth as Net Sales has grown by an annual rate of 9.94% and Operating profit at 7.87% over the last 5 years
3
Positive results in Mar 26
- PAT(Q) At Rs 35.56 cr has Grown at 128.8%
- ROCE(HY) Highest at 16.80%
- DEBT-EQUITY RATIO(HY) Lowest at 0.02 times
4
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 24-Mar-26 and has generated 53.49% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST, DOW and OBV
5
With ROE of 11, it has a Expensive valuation with a 2.7 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 151.19%, its profits have risen by 55% ; the PEG ratio of the company is 0.5
6
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -4.84% over the previous quarter and collectively hold 15.49% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Bliss GVS Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bliss GVS Pharma for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Bliss GVS Pharma
317.81%
2.71
55.73%
Sensex
-11.61%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.30%
EBIT Growth (5y)
9.42%
EBIT to Interest (avg)
15.70
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.74
Tax Ratio
29.82%
Dividend Payout Ratio
4.10%
Pledged Shares
0
Institutional Holding
17.54%
ROCE (avg)
12.39%
ROE (avg)
9.73%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
52
Industry P/E
36
Price to Book Value
5.99
EV to EBIT
42.70
EV to EBITDA
35.15
EV to Capital Employed
6.69
EV to Sales
6.96
PEG Ratio
1.86
Dividend Yield
0.22%
ROCE (Latest)
12.48%
ROE (Latest)
10.95%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
No Trend
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend26What is working for the Company
OPERATING CF(Y)
Highest at Rs 138.72 Cr
ROCE(HY)
Highest at 16.80%
NET SALES(Q)
Highest at Rs 285.58 cr
PBDIT(Q)
Highest at Rs 76.41 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 26.76%
PBT LESS OI(Q)
Highest at Rs 65.88 cr.
PAT(Q)
Highest at Rs 50.10 cr.
EPS(Q)
Highest at Rs 4.72
-3What is not working for the Company
DPR(Y)
Lowest at 4.10%
Loading Valuation Snapshot...
Here's what is working for Bliss GVS Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 65.88 cr has Grown at 138.18%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Operating Cash Flow - Annually
Highest at Rs 138.72 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 285.58 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 285.58 cr has Grown at 37.65%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 76.41 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 26.76%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 65.88 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 50.10 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 4.72
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Bliss GVS Pharma
Dividend Payout Ratio (DPR) - Annually
Lowest at 4.10% and Fallen
each year in the last five yearsMOJO Watch
Company is distributing lower proportion of profits generated as dividend
DPR (%)
